Newmeyer DD, Ferguson-Miller S: Mitochondria: releasing power for life and unleashing the machineries of death. Cell. 2003, 112: 481-490. 10.1016/S0092-8674(03)00116-8.
Article
CAS
PubMed
Google Scholar
D'Alessandro R, Roselli M, Ferroni P, Mariotti S, Spila A, Aloe S, Carone MD, Abbolito MR, Carlini S, Perri P, et al: Serum tissue polypeptide specific antigen (TPS): a complementary tumor marker to CA 15-3 in the management of breast cancer. Breast Cancer Res Treat. 2001, 68: 9-19. 10.1023/A:1017903724176.
Article
PubMed
Google Scholar
Dias N, Bailly C: Drugs targeting mitochondrial functions to control tumor cell growth. Biochem Pharmacol. 2005, 70: 1-12. 10.1016/j.bcp.2005.03.021.
Article
CAS
PubMed
Google Scholar
Neuzil J, Dyason JC, Freeman R, Dong LF, Prochazka L, Wang XF, Scheffler I, Ralph SJ: Mitocans as anti-cancer agents targeting mitochondria: lessons from studies with vitamin E analogues, inhibitors of complex II. J Bioenerg Biomembr. 2007, 39: 65-72. 10.1007/s10863-006-9060-z.
Article
CAS
PubMed
Google Scholar
Neuzil J, Wang XF, Dong LF, Low P, Ralph SJ: Molecular mechanism of 'mitocan'-induced apoptosis in cancer cells epitomizes the multiple roles of reactive oxygen species and Bcl-2 family proteins. FEBS Lett. 2006, 580: 5125-5129. 10.1016/j.febslet.2006.05.072.
Article
CAS
PubMed
Google Scholar
Brenner C, Kroemer G: Apoptosis. Mitochondria--the death signal integrators. Science. 2000, 289: 1150-1151. 10.1126/science.289.5482.1150.
Article
CAS
PubMed
Google Scholar
Galluzzi L, Larochette N, Zamzami N, Kroemer G: Mitochondria as therapeutic targets for cancer chemotherapy. Oncogene. 2006, 25: 4812-4830. 10.1038/sj.onc.1209598.
Article
CAS
PubMed
Google Scholar
Green DR, Reed JC: Mitochondria and apoptosis. Science. 1998, 281: 1309-1312. 10.1126/science.281.5381.1309.
Article
CAS
PubMed
Google Scholar
Don AS, Hogg PJ: Mitochondria as cancer drug targets. Trends Mol Med. 2004, 10: 372-378. 10.1016/j.molmed.2004.06.005.
Article
CAS
PubMed
Google Scholar
Fantin VR, Leder P: Mitochondriotoxic compounds for cancer therapy. Oncogene. 2006, 25: 4787-4797. 10.1038/sj.onc.1209599.
Article
CAS
PubMed
Google Scholar
Scatena R, Bottoni P, Botta G, Martorana GE, Giardina B: The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic. Am J Physiol Cell Physiol. 2007, 293: C12-21. 10.1152/ajpcell.00314.2006.
Article
CAS
PubMed
Google Scholar
Daley E, Wilkie D, Loesch A, Hargreaves IP, Kendall DA, Pilkington GJ, Bates TE: Chlorimipramine: a novel anticancer agent with a mitochondrial target. Biochem Biophys Res Commun. 2005, 328: 623-632. 10.1016/j.bbrc.2005.01.028.
Article
CAS
PubMed
Google Scholar
Athanasiou A, Clarke AB, Turner AE, Kumaran NM, Vakilpour S, Smith PA, Bagiokou D, Bradshaw TD, Westwell AD, Fang L, et al: Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death. Biochem Biophys Res Commun. 2007, 364: 131-137. 10.1016/j.bbrc.2007.09.107.
Article
CAS
PubMed
Google Scholar
Athanasiou A, Smith PA, Vakilpour S, Kumaran NM, Turner AE, Bagiokou D, Layfield R, Ray DE, Westwell AD, Alexander SP, et al: Vanilloid receptor agonists and antagonists are mitochondrial inhibitors: how vanilloids cause non-vanilloid receptor mediated cell death. Biochem Biophys Res Commun. 2007, 354: 50-55. 10.1016/j.bbrc.2006.12.179.
Article
CAS
PubMed
Google Scholar
Dong LF, Freeman R, Liu J, Zobalova R, Marin-Hernandez A, Stantic M, Rohlena J, Valis K, Rodriguez-Enriquez S, Butcher B, et al: Suppression of tumor growth in vivo by the mitocan alpha-tocopheryl succinate requires respiratory complex II. Clin Cancer Res. 2009, 15: 1593-1600. 10.1158/1078-0432.CCR-08-2439.
Article
CAS
PubMed
Google Scholar
Aloysius MM, Zaitoun AM, Bates TE, Albasri A, Ilyas M, Rowlands BJ, Lobo DN: Complete absence of M2-pyruvate kinase expression in benign pancreatic ductal epithelium and pancreaticobiliary and duodenal neoplasia. BMC Cancer. 2009, 9: 327-10.1186/1471-2407-9-327.
Article
PubMed
PubMed Central
Google Scholar
Friedrichs K, Gluba S, Eidtmann H, Jonat W: Overexpression of p53 and prognosis in breast cancer. Cancer. 1993, 72: 3641-3647. 10.1002/1097-0142(19931215)72:12<3641::AID-CNCR2820721215>3.0.CO;2-8.
Article
CAS
PubMed
Google Scholar
Imai Y, Sasaki T, Fujibayashi T: Volume-corrected mitotic index as a prognostic factor in oral squamous cell carcinomas. Oral Oncol. 2001, 37: 72-76. 10.1016/S1368-8375(00)00061-0.
Article
CAS
PubMed
Google Scholar
Hanahan D, Weinberg RA: The hallmarks of cancer. Cell. 2000, 100: 57-70. 10.1016/S0092-8674(00)81683-9.
Article
CAS
PubMed
Google Scholar
Guzy RD, Hoyos B, Robin E, Chen H, Liu L, Mansfield KD, Simon MC, Hammerling U, Schumacker PT: Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab. 2005, 1: 401-408. 10.1016/j.cmet.2005.05.001.
Article
CAS
PubMed
Google Scholar
Guzy RD, Schumacker PT: Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. Exp Physiol. 2006, 91: 807-819. 10.1113/expphysiol.2006.033506.
Article
CAS
PubMed
Google Scholar
Powell CS, Jackson RM: Mitochondrial complex I, aconitase, and succinate dehydrogenase during hypoxia-reoxygenation: modulation of enzyme activities by MnSOD. Am J Physiol Lung Cell Mol Physiol. 2003, 285: L189-198.
Article
CAS
PubMed
Google Scholar
Ghaneh P, Costello E, Neoptolemos JP: Biology and management of pancreatic cancer. Gut. 2007, 56: 1134-1152. 10.1136/gut.2006.113068.
Article
CAS
PubMed
PubMed Central
Google Scholar
Takhar AS, Palaniappan P, Dhingsa R, Lobo DN: Recent developments in diagnosis of pancreatic cancer. BMJ. 2004, 329: 668-673. 10.1136/bmj.329.7467.668.
Article
PubMed
PubMed Central
Google Scholar
Schneider G, Siveke JT, Eckel F, Schmid RM: Pancreatic cancer: basic and clinical aspects. Gastroenterology. 2005, 128: 1606-1625. 10.1053/j.gastro.2005.04.001.
Article
CAS
PubMed
Google Scholar
Cardoso CM, Custodio JB, Almeida LM, Moreno AJ: Mechanisms of the deleterious effects of tamoxifen on mitochondrial respiration rate and phosphorylation efficiency. Toxicol Appl Pharmacol. 2001, 176: 145-152. 10.1006/taap.2001.9265.
Article
CAS
PubMed
Google Scholar
Gottlieb E, Tomlinson IP: Mitochondrial tumour suppressors: a genetic and biochemical update. Nat Rev Cancer. 2005, 5: 857-866. 10.1038/nrc1737.
Article
CAS
PubMed
Google Scholar